glp-1 weight loss drug news Alarming rise in overdoses Eli Lilly to seek approval

Xie Y, Bowe B, Xian H, Loux T, McGill JB, Al-Aly Z

130 (7), 833841.e3

Lastly, a study evaluating the impact of IL-1 gene polymorphism, leading to increased IL-1 levels, was shown to correlate with an increased rate of kidney disease in T2DM, mainly diabetic nephropathy [8]

DPP4 inhibitor induces beta cell regeneration and DDR-1 protein expression as an endocrine progenitor cell marker in neonatal STZ-diabetic rats

191 The mechanism of GLP-1 RA to improve dopaminergic degeneration and pathological -synuclein aggregation in the PD model may involve inhibiting the PI3K/Akt/mTOR pathway 192 and enhancing AMPK/PGC-1a signaling pathway

We need to identify who benefits the most and focus our efforts there. Hwang is currently working on a follow-up project to refine clinical guidelines for prescribing GLP-1 drugs more selectively